Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Acq. announced
Director departure
Quarterly results
|
|
VBI VACCINES INC. (VBIV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/05/2019 |
GN
| VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference |
| 07/01/2019 |
GN
| VBI Vaccines Added to Russell 2000® and Russell 3000® Indexes |
| 06/20/2019 |
GN
| VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference |
| 06/17/2019 |
GN
| VBI Vaccines Announces Positive Top-Line Results from PROTECT, a Pivotal Phase 3 Study of Sci-B-Vac® |
| 06/16/2019 |
GN
| VBI Vaccines to Host Conference Call Tomorrow to Review PROTECT Phase 3 Clinical Data for Sci-B-Vac® |
| 06/13/2019 |
GN
| VBI Vaccines Announces Results of Annual General Meeting |
| 05/01/2019 |
GN
| VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update |
| 04/19/2019 |
GN
| New Research Coverage Highlights Turquoise Hill Resources, GDS HOLDINGS, AptarGroup, VBI Vaccines, Loral Space and Communications, and FEDNAT HOLDING CO — Consolidated Revenues, Company Growth, and Expectations for 2019 |
| 04/17/2019 |
GN
| VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs |
| 04/11/2019 |
GN
| VBI Vaccines Appoints Joanne Cordeiro to Board of Directors |
| 04/09/2019 |
GN
| VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019 |
| 01/16/2019 |
GN
| VBI Vaccines Appoints Blaine McKee to Board of Directors |
| 12/20/2018 |
GN
| VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate |
| 12/18/2018 |
GN
| VBI Vaccines Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriter's Option to Purchase Additional Shares for Aggregate Gross Proceeds of $42.9 Million |
| 12/13/2018 |
GN
| VBI Vaccines Announces Pricing of $37.5 Million Public Offering |
| 12/12/2018 |
GN
| VBI Vaccines Announces Proposed Public Offering of Common Shares |
| 11/09/2018 |
GN
| VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update |
| 09/26/2018 |
GN
| VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards |
| 09/16/2018 |
GN
| VBI Vaccines Responds to Unfounded Allegations in Globes Article |
| 08/28/2018 |
GN
| VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference |
| 08/14/2012 |
GN
| Paulson Capital Corp. Reports Second Quarter 2012 Results |
| 07/05/2012 |
GN
| Paulson Investment Company Adds Two Key Employees |
| 05/14/2012 |
GN
| Paulson Capital Corp. Reports First Quarter 2012 Results |
| 04/16/2012 |
GN
| Paulson Capital Corp. Closes Previously Announced Transfer of Retail Business to JHS Capital Advisors and Pays $.05 Special Dividend to Shareholders |
| 03/21/2012 |
GN
| Paulson Capital Corp. Regains Compliance With Nasdaq Listing Rule 5550(a)(2) |
| 03/08/2012 |
GN
| Paulson Capital Corp. Reports Year End 2011 Results |
| 12/02/2011 |
GN
| Paulson Investment Company, Inc. Completes $4,800,000 Initial Public Offering for Vanguard Energy Corporation |
| 11/10/2011 |
GN
| Paulson Capital Corp. Reports Third Quarter 2011 Results |
| 08/11/2011 |
GN
| Paulson Capital Corp. Reports Second Quarter 2011 Results |
|
|